Literature DB >> 24461617

Bronchodilator reversibility in chronic obstructive pulmonary disease: use and limitations.

Peter M A Calverley1, Paul Albert2, Paul P Walker2.   

Abstract

The change in forced expiratory volume in 1 s (FEV1) after administration of a short-acting bronchodilator has been widely used to identify patients with chronic obstructive pulmonary disease (COPD) who have a potentially different disease course and response to treatment. Despite the apparent simplicity of the test, it is difficult to interpret or rely on. Test performance is affected by the day of testing, the severity of baseline lung-function impairment, and the number of drugs given to test. Recent data suggest that the response to bronchodilators is not enhanced in patients with COPD and does not predict clinical outcomes. In this Review we will discuss the insight that studies of bronchodilator reversibility have provided into the nature of the COPD, and how the abnormal physiology seen in patients with this disorder can be interpreted.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24461617     DOI： 10.1016/S2213-2600(13)70086-9

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


  25 in total

1.  Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.

Authors:  Spyridon Fortis; Alejandro Comellas; Barry J Make; Craig P Hersh; Sandeep Bodduluri; Dimitris Georgopoulos; Victor Kim; Gerard J Criner; Mark T Dransfield; Surya P Bhatt
Journal:  Ann Am Thorac Soc       Date:  2019-07

2.  Radiological correlates and clinical implications of the paradoxical lung function response to β₂ agonists: an observational study.

Authors:  Surya P Bhatt; James M Wells; Victor Kim; Gerard J Criner; Craig P Hersh; Megan Hardin; William C Bailey; Hrudaya Nath; Young-Il Kim; Marilyn G Foreman; Douglas S Stinson; Carla G Wilson; Stephen I Rennard; Edwin K Silverman; Barry J Make; Mark T Dransfield
Journal:  Lancet Respir Med       Date:  2014-09-09       Impact factor: 30.700

3.  A New Bronchodilator Response Grading Strategy Identifies Distinct Patient Populations.

Authors:  James E Hansen; Asli G Dilektasli; Janos Porszasz; William W Stringer; Youngju Pak; Harry B Rossiter; Richard Casaburi
Journal:  Ann Am Thorac Soc       Date:  2019-12

4.  Differences in the use of spirometry between rural and urban primary care centers in Spain.

Authors:  Eduardo Márquez-Martín; Joan B Soriano; Myriam Calle Rubio; Jose Luis Lopez-Campos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-08-17

5.  Regional variations in the prevalence and misdiagnosis of air flow obstruction in China: baseline results from a prospective cohort of the China Kadoorie Biobank (CKB).

Authors:  Om P Kurmi; Liming Li; Margaret Smith; Mareli Augustyn; Junshi Chen; Rory Collins; Yu Guo; Yabin Han; Jingxin Qin; Guanqun Xu; Jian Wang; Zheng Bian; Gang Zhou; Kourtney Davis; Richard Peto; Zhenming Chen; Liming Li; Zhengming Chen; Junshi Chen; Rory Collins; Richard Peto; Zhengming Chen; Garry Lancaster; Xiaoming Yang; Alex Williams; Margaret Smith; Ling Yang; Yumei Chang; Iona Millwood; Yiping Chen; Sarah Lewington; Sam Sansome; Robin Walters; Om Kurmi; Yu Guo; Zheng Bian; Can Hou; Yunlong Tan; Zheng Wang; Xin Cai; Huiyan Zhou; Xuguan Chen; Zengchang Pang; Shanpeng Li; Shaojie Wang; Silu Lv; Zhonghou Zhao; Shumei Liu; Zhigang Pang; Liqiu Yang; Hui He; Bo Yu; Shanqing Wang; Hongmei Wang; Chunxing Chen; Xiangyang Zheng; Xiaoshu Hu; Minghao Zhou; Ming Wu; Ran Tao; Yeyuan Wang; Yihe Hu; Liangcai Ma; Renxian Zhou; Zhenzhu Tang; Naying Chen; Ying Huang; Mingqiang Li; Zhigao Gan; Jinhuai Meng; Jingxin Qin; Xianping Wu; Ningmei Zhang; Guojin Luo; Xiangsan Que; Xiaofang Chen; Pengfei Ge; Xiaolan Ren; Caixia Dong; Hui Zhang; Enke Mao; Zhongxiao Li; Gang Zhou; Shixian Feng; Yulian Gao; Tianyou He; Li Jiang; Huarong Sun; Min Yu; Danting Su; Feng Lu; Yijian Qian; Kunxiang Shi; Yabin Han; Lingli Chen; Guangchun Li; Huilin Liu; Li Yin; Youping Xiong; Zhongwen Tan; Weifang Jia
Journal:  BMJ Open Respir Res       Date:  2014-05-09

Review 6.  Clinical role of dual bronchodilation with an indacaterol-glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of life.

Authors:  Andrea Rossi; Erika Zanardi; Venerino Poletti; Mario Cazzola
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-23

7.  Integrating COPD care in Italy.

Authors:  Peter Ma Calverley
Journal:  Multidiscip Respir Med       Date:  2014-05-19

8.  Health-related quality of life and chronic obstructive pulmonary disease in early stages - longitudinal results from the population-based KORA cohort in a working age population.

Authors:  Margarethe E Wacker; Matthias Hunger; Stefan Karrasch; Joachim Heinrich; Annette Peters; Holger Schulz; Rolf Holle
Journal:  BMC Pulm Med       Date:  2014-08-09       Impact factor: 3.317

9.  Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.

Authors:  Veronika Müller; Gabriella Gálffy; Márta Orosz; Zsuzsanna Kováts; Balázs Odler; Olof Selroos; Lilla Tamási
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-01-12

10.  Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary disease.

Authors:  Roberto Rodriguez-Roisin; Kay Tetzlaff; Henrik Watz; Emiel Fm Wouters; Bernd Disse; Helen Finnigan; Helgo Magnussen; Peter Ma Calverley
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.